||Uncertainties identified from carers' questions
||James Lind Alliance Palliative and end of life care Priority Setting Partnership
|Why is there uncertainty?
||Reliable up-to-date systematic reviews have revealed important continuing uncertainties about treatment effects
Ranked 22nd in the PeolcPSP
This uncertainty was identified by two carer's, two professional's and six bereaved carer's question.
This is an indicative uncertainty and the following submissions were merged to form this one:
How to diagnose dying-are there any biomedical markers which may prevent the subjectivity of the process.
Were you offered any advice/support in how to inform your family/friends/colleagues about your impending death.
Quality of life is important, companion and friends with an understanding of their personal type of disease & likely progression. If they are able to understand an explanation of their drug regimes and reasons for each, with possible side effects
References to reliable up-to-date systematic reviews:
|What is needed?
|Systematic reviews that need updating or extending
|Systematic reviews in preparation
|Ongoing controlled trials
|Which health conditions?
||Symptoms | Service delivery, organisation and staffing | Palliative and end of life care
|What is person's age?
|Which types of treatments?
||Mixed or complex
Health related quality of life, good death, Change in symptoms or change in management of symptoms, adverse effects or complications
||Publication date:08 Sep 2015
|Last reviewed date:08 Sep 2016
||Publication Type:Known Uncertainty
|The DUETs team endeavours to ensure that information is correct at the time of data entry